tiprankstipranks

Beijing Airdoc’s H1 2024: Revenue Up, Net Loss Doubles

Beijing Airdoc’s H1 2024: Revenue Up, Net Loss Doubles

Beijing Airdoc Technology Co. Ltd. Class H (HK:2251) has released an update.

Confident Investing Starts Here:

Beijing Airdoc Technology Co. Ltd. reports a revenue increase to RMB 93,710,000 for the first half of 2024, although the firm also experienced a significant net loss of RMB 81,488,000 during the same period. The company’s unaudited financial results, reviewed by Ernst & Young, indicate a doubling in loss per share from the previous year. Despite these losses, the company still maintains a solid financial position with total equity attributable to shareholders at RMB 1,455,242,000.

For further insights into HK:2251 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1